Synthesis and antimicrobial activity of sulfide and sulfone derivatives of 4-(2-chloro-4-fluorophenyl)-1,3-thiazol-2-amine/acetamide

Pharmaceutical Chemistry Journal

Volumn 46, Issue 11, 2013, Pages 667-671

  Badiger, N P ^a,b   Mulla, J S ^a   Khazi, Iqbal ^a   Khazi, I M ^a  

^a KARNATAK UNIVERSITY   (India)

^b SDM COLLEGE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

antimicrobial activity; sulfides; sulfones; Thiazole

Indexed keywords

4 (2 CHLORO 4 FLUOROPHENYL) 1,3 THIAZOL 2 AMINE; 4 (2 CHLORO 4 FLUOROPHENYL) 5 (4 CHLOROPHENYLSULFANYL) THIAZOL 2 YLAMINE; 4 (2 CHLORO 4 FLUOROPHENYL) 5 (TOLUENE 4 SULFONYL) THIAZOL 2 YLAMINE; 4 (2 CHLORO 4 FLUOROPHENYL) 5 4 TOLYLSULFANYL THIAZOL 2 YLAMINE; 4 (2 CHLORO 4 FLUOROPHENYL) 5 PHENYLSULFANYL THIAZOL 2 YLAMINE; 5 (4 CHLOROBENZENESULFONYL) 4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YLAMINE; 5 BENZENESULFONYL 4 (2 CHLORO 4 FLUOROPHENYL) THIAZO 1 2 YLAMINE; 5 BROMO 4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YLAMINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GRISEOFULVIN; N [4 (2 CHLORO 4 FLUOROPHENYL) 5 (4 CHLOROPHENYLSULFANYL) THIAZOL 2 YL] ACETAMIDE; N [4 (2 CHLORO 4 FLUOROPHENYL) 5 (TOLUENE 4 SULFONYL) THIAZOL 2 YL] ACETAMIDE; N [4 (2 CHLORO 4 FLUOROPHENYL) 5 4 TOLYLSULFANYL THIAZOL 2 YL] ACETAMIDE; N [4 (2 CHLORO 4 FLUOROPHENYL) 5 PHENYLSULFANYL THIAZOL 2 YL] ACETAMIDE; N [4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YL] ACETAMIDE; N [5 (4 CHLOROBENZENESULFONYL) 4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YL] ACETAMIDE; N [5 BROMO 4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YL] ACETAMIDE; N [BENZENESULFONYL 4 (2 CHLORO 4 FLUOROPHENYL) THIAZOL 2 YL] ACETAMIDE; NORFLOXACIN; SULFIDE; SULFONE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BROMINATION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SUBSTITUTION REACTION;

EID: 84879693892     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-013-0866-9     Document Type: Article

References (13)

1. S. K. C. Lai, K. Lam, K. M. Chu, et al., New Engl. J. Med., 346, 2033 (2002).
2. M. Sovova and P. Sova, Ceska Slov. Farm., 52, 82 (2003).
3. B. Kotelanski, R. J. Grozmann, and J. N. C. Cohn, Pharmacol. Ther., 14, 427 (1973).
4. R. Schmied, G. X. Wang, and M. Korth, Circ. Res., 68, 597 (1991).
5. A. V. Nieves and A. E. Lang, Clin. Neuropharmacol., 25, 111 (2002).
6. S. Padmanabhan, R. C. Lavin, and G. J. Durant, Tetrahedron-Asymmetr., 11, 455 (2000).
7. G. A. H. Buttle, D. Stephenson, S. Smith, et al., Lancet, 1, 1331-1333 (1937)
8. Chem. Abstr., 31, 7118 (1937).
9. D. C. Thienopont, O. F. J. Vanparijis, A. H. M. Raeymaekers, et al., Nature, 209, 1084-1087 (1966).
10. R. S. Koti, N. S. Shetty, N. P. Badiger, and I. M. Khazi, J. Sulfur. Chem., 29, 539-547 (2008).
11. J. Renuka Shipra. J. Indian Chem. Soc., 74, 54-55 (1997).
12. E. J. Threlfall, I. S. T. Fisher, L. Ward, et al., Microb. Drug Resist., 5, 195-199 (1999).
13. R. D. Walker, Antimicrobial Susceptibility Testing and Interpretation of Results, in: Antimicrobial Therapy in Veterinary Medicine, J. F. Prescott, J. D. Baggot, and R. D. Walke (Eds.), Iowa State University Press, Ames, IA (2000), pp. 12-26.